Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?
- PMID: 33092944
- DOI: 10.1016/j.clon.2020.10.005
Does Concurrent Use of CDK4/6 Inhibitors During Palliative Radiotherapy Increase Toxicity in Patients With Metastatic Breast Cancer?
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
